Current state of signaling pathways associated with the pathogenesis of idiopathic pulmonary fibrosis

被引:0
|
作者
Zhou, Yang [1 ]
Ling, Tingting [1 ]
Shi, Weihong [1 ]
机构
[1] Jiangsu Vocat Coll Med, Sch Med, Yancheng 224005, Jiangsu, Peoples R China
关键词
Idiopathic pulmonary fibrosis; Signaling pathways; Review; LUNG FIBROSIS; GROWTH-FACTOR; INHIBITION; CELLS; DIFFERENTIATION; RECEPTOR; MODEL; BETA; MICE; TRANSITION;
D O I
10.1186/s12931-024-02878-z
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Idiopathic Pulmonary Fibrosis (IPF) represents a chronic and progressive pulmonary disorder distinguished by a notable mortality rate. Despite the elusive nature of the pathogenic mechanisms, several signaling pathways have been elucidated for their pivotal roles in the progression of this ailment. This manuscript aims to comprehensively review the existing literature on the signaling pathways linked to the pathogenesis of IPF, both within national and international contexts. The objective is to enhance the comprehension of the pathogenic mechanisms underlying IPF and offer a scholarly foundation for the advancement of more efficacious therapeutic strategies, thereby fostering research and clinical practices within this domain.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Role of MicroRNAs in Signaling Pathways Associated with the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Focus on Epithelial-Mesenchymal Transition
    Cadena-Suarez, Ana Ruth
    Hernandez-Hernandez, Hilda Arely
    Alvarado-Vasquez, Noe
    Rangel-Escareno, Claudia
    Sommer, Bettina
    Negrete-Garcia, Maria Cristina
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
  • [2] Idiopathic pulmonary fibrosis: The current state of the problem
    Shmelev, E. I.
    [J]. TERAPEVTICHESKII ARKHIV, 2016, 88 (12): : 103 - 108
  • [3] Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis
    Nour C. Bacha
    Adeline Blandinieres
    Elisa Rossi
    Nicolas Gendron
    Nathalie Nevo
    Séverine Lecourt
    Coralie L. Guerin
    Jean Marie Renard
    Pascale Gaussem
    Eduardo Angles-Cano
    Chantal M. Boulanger
    Dominique Israel-Biet
    David M. Smadja
    [J]. Stem Cell Reviews and Reports, 2018, 14 : 223 - 235
  • [4] Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis
    Bacha, Nour C.
    Blandinieres, Adeline
    Rossi, Elisa
    Gendron, Nicolas
    Nevo, Nathalie
    Lecourt, Severine
    Guerin, Coralie L.
    Renard, Jean Marie
    Gaussem, Pascale
    Angles-Cano, Eduardo
    Boulanger, Chantal M.
    Israel-Biet, Dominique
    Smadja, David M.
    [J]. STEM CELL REVIEWS AND REPORTS, 2018, 14 (02) : 223 - 235
  • [5] Pathogenesis of idiopathic pulmonary fibrosis
    Nunes, H
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2003, 20 (05) : S100 - S102
  • [6] Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment
    Khalil, N
    O'Connor, R
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (02) : 153 - 160
  • [7] Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis
    Loomis-King, Hillary
    Flaherty, Kevin R.
    Moore, Bethany B.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (03) : 377 - 385
  • [8] PATHOGENESIS OF IDIOPATHIC PULMONARY FIBROSIS
    BUHL, R
    MEIERSYDOW, J
    VOGELMEIER, C
    [J]. IMMUNITAT UND INFEKTION, 1995, 23 (03): : 92 - 96
  • [9] Pathogenesis of Idiopathic Pulmonary Fibrosis
    Wolters, Paul J.
    Collard, Harold R.
    Jones, Kirk D.
    [J]. ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9, 2014, 9 : 157 - 179
  • [10] Why do patients get idiopathic pulmonary fibrosis? Current concepts in the pathogenesis of pulmonary fibrosis
    Pierre-Simon Bellaye
    Martin Kolb
    [J]. BMC Medicine, 13